HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chad E Mire Selected Research

Ebola virus nucleoprotein VP35

7/2013Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chad E Mire Research Topics

Disease

28Infections
02/2022 - 07/2011
20Vesicular Stomatitis
08/2021 - 12/2009
7Ebola Hemorrhagic Fever
08/2021 - 01/2016
4Henipavirus Infections
11/2020 - 12/2013
4Fever (Fevers)
01/2020 - 08/2015
3COVID-19
04/2022 - 01/2021
3Weight Loss (Weight Reduction)
02/2022 - 01/2021
3Virus Diseases (Viral Diseases)
11/2020 - 12/2015
3Lassa Fever (Fever, Lassa)
01/2019 - 01/2016
3Marburg Virus Disease
10/2015 - 02/2014
2Paramyxoviridae Infections (Parainfluenza)
04/2022 - 08/2015
2Lymphopenia (Lymphocytopenia)
10/2021 - 01/2017
2Hantavirus Infections
07/2021 - 01/2021
2Human Influenza (Influenza)
01/2017 - 01/2016
1Inflammation (Inflammations)
02/2022
1Cytokine Release Syndrome
01/2020
1Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever)
01/2019
1Crimean Hemorrhagic Fever
01/2019
1Dengue (Dengue Fever)
01/2017
1Gaucher Disease (Gaucher's Disease)
01/2017
1Disseminated Intravascular Coagulation
10/2015
1Viremia
10/2015
1Venezuelan Equine Encephalomyelitis
08/2015
1Filoviridae Infections
01/2014
1Nervous System Diseases (Neurological Disorders)
12/2013

Drug/Important Bio-Agent (IBA)

23VaccinesIBA
04/2022 - 01/2012
20Glycoproteins (Glycoprotein)IBA
11/2020 - 12/2009
10Monoclonal AntibodiesIBA
07/2021 - 06/2014
7Antiviral Agents (Antivirals)IBA
02/2022 - 12/2015
6Proteins (Proteins, Gene)FDA Link
10/2015 - 12/2009
4CytokinesIBA
01/2020 - 10/2015
4Small Interfering RNA (siRNA)IBA
12/2017 - 02/2014
3AntibodiesIBA
01/2019 - 01/2016
3LipidsIBA
01/2016 - 02/2014
2nitazoxanide (NTZ)FDA Link
02/2022 - 09/2019
2Pharmaceutical PreparationsIBA
02/2022 - 12/2015
2Neutralizing AntibodiesIBA
10/2021 - 01/2021
22019-nCoV Vaccine mRNA-1273IBA
10/2021 - 01/2021
2AerosolsIBA
11/2020 - 10/2016
2Combined VaccinesIBA
01/2018 - 01/2018
2Viral ProteinsIBA
01/2016 - 07/2011
2GTP-Binding Proteins (G-Protein)IBA
10/2015 - 12/2013
1COVID-19 VaccinesIBA
04/2022
1COVA1-18IBA
10/2021
1remdesivirIBA
01/2021
1EpitopesIBA
11/2020
1HLA-DR Antigens (HLA-DR)IBA
01/2020
1Polysaccharides (Glycans)IBA
11/2018
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2018
1ChemokinesIBA
01/2017
1miglustat (Zavesca)FDA Link
01/2017
1InterferonsIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
11/2016
1umifenovirIBA
01/2016
1Pathogen-Associated Molecular Pattern MoleculesIBA
12/2015
1Fibrinogen (Factor I)FDA Link
10/2015
1FibrinIBA
10/2015
1EnzymesIBA
10/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2015
1Protein CIBA
10/2015
1Antifibrinolytic Agents (Antifibrinolytics)IBA
10/2015
1salicylhydroxamic acid (SHAM)IBA
10/2015
1Subunit VaccinesIBA
05/2014
1Lipid NanoparticlesIBA
02/2014
1attachment protein GIBA
12/2013
1AntigensIBA
12/2013
1Ebola virus nucleoprotein VP35IBA
07/2013
1Peptide Hydrolases (Proteases)FDA Link
07/2011
1Matrix-MIBA
12/2009

Therapy/Procedure

8Therapeutics
02/2022 - 02/2014
1Enteral Nutrition (Feeding, Tube)
01/2017